HMy2 Cells

The HMy2 cell line is a human B lymphoblastoid cell line derived from an adult individual. This cell line was originally established for the study of human B cell function, lymphoma, and immunological responses. The HMy2 cells are commonly used in research due to their capacity to produce a wide range of immunoglobulins and cytokines, which makes them an excellent model for investigating B cell activation, differentiation, and the molecular mechanisms underlying lymphoid malignancies. HMy2 cells exhibit typical characteristics of B lymphoblastoid cells, such as a high nuclear-to-cytoplasmic ratio and the presence of surface markers indicative of B cell lineage, including CD19 and CD20. These cells are also known to express HLA-DR antigens, making them suitable for studies related to antigen presentation and immune response modulation. Researchers often utilize HMy2 cells in experiments involving gene expression, transfection, and hybridoma technology, contributing to advancements in therapeutic antibody development and cancer immunotherapy. B lymphoblast cell lines, Hematopoietic, Plasma cell leukemia, Growth Conditions: Suspension, Biosafety level: BSL 1